Ian Robert Burton Hudson OBE is a British physician and former government official who served as the chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA) from 2013 to 2019.
Hudson practised as a paediatrician from 1982 to 1989, and then worked in clinical research and development in the pharmaceutical industry, lately as a vice president of SmithKline Beecham, between 1989 and 2001.
He was also the UK delegate to the European Medicines Agency's Committee for Human Medicinal Products, CHMP, (2002-2013), latterly its vice chair and honorary Senior Lecturer in Clinical Pharmacology, William Harvey Research Institute, Queen Mary and Westfield College, university of London (2007-2012).
In September 2013 he became chief executive of the Medicines and Healthcare products Regulatory Agency, succeeding Sir Kent Woods.
He was also the Chair of the International Review Panel for clinical trial accreditation, UKCRC Clinical Trials Unit Network, a member of the Centre for Innovation in Regulatory Science scientific advisory board, and a member of the scientific advisory council of TOPRA.